The cash flow of Amgen Inc. over the past 10 years
Chart Amgen Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Amgen Inc.'s operating cash flow was $9.96B and its capital expenditures $1.86B, leaving free cash flow of $8.1B. Free cash flow was above zero in all 10 years shown. It ranged from $7.36B in fiscal 2023 to $10.56B in fiscal 2018. Capital expenditures were highest in fiscal 2025, at $1.86B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $9.96B | $1.86B | $8.1B |
| 2024ended Dec 31, 2024 | $11.49B | $1.1B | $10.39B |
| 2023ended Dec 31, 2023 | $8.47B | $1.11B | $7.36B |
| 2022ended Dec 31, 2022 | $9.72B | $936M | $8.79B |
| 2021ended Dec 31, 2021 | $9.26B | $880M | $8.38B |
| 2020ended Dec 31, 2020 | $10.5B | $608M | $9.89B |
| 2019ended Dec 31, 2019 | $9.15B | $618M | $8.53B |
| 2018ended Dec 31, 2018 | $11.3B | $738M | $10.56B |
| 2017ended Dec 31, 2017 | $11.18B | $664M | $10.51B |
| 2016ended Dec 31, 2016 | $10.35B | $738M | $9.62B |
Fiscal years as Amgen Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Amgen Inc.
- The revenue of Amgen Inc.
- The profitability of Amgen Inc.
- The debt of Amgen Inc.
- The dividends of Amgen Inc.
- All of Amgen Inc.'s financials, charted
Companies of a similar size
- IBMINTERNATIONAL BUSINESS MACHINES CORPORATION
- LINLinde plc
- TMOTHERMO FISHER SCIENTIFIC INC.
- ARMARM HOLDINGS PLC /UK
- WFCWELLS FARGO & COMPANY/MN
Not investment advice. This page shows what Amgen Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.